Sign Up to like & get
recommendations!
0
Published in 2018 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2018.1467539
Abstract: Abstract Interferon-beta (IFNβ) is effective treatments for relapsing multiple sclerosis (MS). IFNβ treatment includes subcutaneous (SC) IFNβ-1b, intramuscular (IM) and SC IFNβ-1a, and SC pegylated IFNβ-1a (PEG-IFNβ-1a). PEG-IFNβ-1a offers the advantage of a prolonged duration…
read more here.
Keywords:
interferon beta;
injection site;
site reactions;
multiple sclerosis ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.17341
Abstract: Local reactions to SARS-CoV-2 vaccination are common and mainly occur within the first week, albeit also seen later.1 Here, we address another aspect of cutaneous side effects to SARS-CoV-2 vaccination and draw attention to implications…
read more here.
Keywords:
injection site;
incorrect subcutaneous;
site reactions;
subcutaneous administration ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Journal of the European Academy of Dermatology and Venereology"
DOI: 10.1111/jdv.17683
Abstract: Currently available COVID-19 vaccines have shown a good safety profile. However, adverse effects such as local reactions have been frequently observed. Based on existing evidence, after administering the BNT162b2 (Pfizer) or AZD1222 (AstraZeneca) vaccines, more…
read more here.
Keywords:
injection site;
atypical injection;
injection;
site reactions ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Science Progress"
DOI: 10.1177/00368504221096539
Abstract: Background: Thiamine, also known as vitamin B1, is an essential water-soluble micronutrient. Although thiamine has minimal safety concerns, parenteral administration has been associated with rare cases of anaphylactic shock, cardiac arrest, and injection site reaction.…
read more here.
Keywords:
thiamine;
site reactions;
injection site;
push ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155218769347
Abstract: Purpose Fosaprepitant (Emend®) is an antiemetic frequently used for the prevention of chemotherapy-induced nausea and vomiting. We previously documented an overall 28.7% incidence of infusion-site reactions in patients receiving fosaprepitant via peripheral venous access. These…
read more here.
Keywords:
incidence;
infusion;
infusion site;
site reactions ... See more keywords